Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

The Impacts of COVID-19 on Mental Health, Substance Use, and Overdose Concerns of People Who Use Drugs in Rural Communities

Investigate the impact of COVID-19 on the mental health, substance use, and overdose concerns among people who use drugs (PWUDs) in rural communities
Original research | 2021
Illegal drugs, Rural/remote, Mental health

The perceived risk of illicit drug use and views on drug policy in the general population

This article analyzes the riskiness attached to illicit drug use by means of a social representations framework.
Original research | 2021
Policy/Regulatory, Illegal drugs

The use of diverted pharmaceutical opioids is associated with reduced risk of fentanyl exposure among people using unregulated drugs in Vancouver, Canada

The aim of this study was to assess the effects of using diverted POs on fentanyl exposure.
Original research | 2021
Evidence base, Harm reduction, Hesitancy of prescribers , Safer supply, Advocacy, About prescribers, Outcomes

Tracing a path for opium gum from Mexico as a safe supply harm reduction measure for Canada

Discusses the political and legal possibilities of safely supplying opium gum and manually extracted heroin from Mexico to Canada as a public health, harm reduction and development policy.

Commentary | 2021
Policy/Regulatory, Safer supply

Visualizing harm reduction: Methodological and ethical considerations

This paper explores the opportunities and constraints of using photo-based methods in the context of a community-based participatory research study on how to engage people living with HIV in conversat
Original research | 2015
Wrap-around services, Social services, Hospitals

“About Nothing Without Us”: A Comparative Analysis of Autonomous Organizing Among People Who Use Drugs and Psychiatrized Groups in Canada

Paralleling the development of autonomous organizations of PUD in relation to independent groups by and for various psychiatrized constituencies, this article traces the history of Canadian drug/ser
Commentary | 2016
Advocacy, About PWUD, Barriers and enablers, Illegal drugs, Peer/PWLLE program involvement

A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada

To elicit in-depth knowledge from PWUD with lived experience of accessing services to better understand their unmet treatment and service needs, towards closing the service and treatment gap in Ontari
Original research | 2021
Policy/Regulatory, Wrap-around services, Advocacy, About PWUD, Barriers and enablers, Housing, Illegal drugs, Peer/PWLLE program involvement, Stigma

A qualitative study on overdose response in the era of COVID-19 and beyond: how to spot someone so they never have to use alone

During COVID-19 restrictions, remote spotting (e.g., using a telephone, video call, and/or a social media app) emerged to address physical distancing requirements and reduced access to harm reduction
Original research | 2021
Overdose, Harm reduction, Policy/Regulatory, Decriminalization/legalization, About PWUD, Barriers and enablers, Illegal drugs, Rural/remote, SCS/OPS

Associations between discrimination and substance use among college students in the United States from 2015–2019

This study uses 2015–2019 National College Health Assessment data to determine whether college students reporting discrimination due to sexual orientation, race/ethnicity, gender, or age report greate
Original research | 2021
Equity, Illegal drugs

Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, Part 1: Prevalence and characteristics

The aim of this study was to evaluate breakthrough pain in opioid-treated ambulatory patients with chronic cancer or noncancer pain treated in community practices.
Original research | 2010
About prescribers, Chronic pain

COVID-19, the Opioid Epidemic and the Housing Crisis

Commentary | 2020
Overdose, Advocacy, Housing, Illegal drugs, Drug checking

Crushed it: Elucidation of systemic vasculitis caused by injected hydromorphone tablets via skin biopsy

Describes a case of medical complications from injected hydromorphone tablets
Case study | 2019
About prescribers, Injecting drugs

Down the drain: Reconsidering routine urine drug testing during the COVID-19 pandemic

We discuss how COVID-19 has ended the practice of “routine” UDT in office-based opioid treatment (OBOT), encouraged a more patient-centered approach, and why targeted, as opposed to routine, UDT shoul
Commentary | 2020
Evidence base, Policy/Regulatory, About prescribers

Increasing diversion of methadone in Vancouver, Canada, 2005–2015

Recent studies have found that methadone was identified in more than a quarter of prescription opioid-related deaths among people who use illicit drugs in Vancouver, Canada.
Original research | 2018
Evidence base, Harm reduction, Safer supply, About prescribers, Substitution/OAT, Diversion

Injection of drug residue as a potential risk factor for HCV acquisition among Montréal young injection drug users

Examine the specific practice of injecting someone else's drug residue as a possible route of HCV transmission.
Original research | 2012
Evidence base, Safer supply, Illegal drugs, Youth

Legalization of recreational cannabis: Facilitators and barriers to switching from an illegal to a legal source

This study aimed to identify perceived facilitators/barriers of switching from an illicit to a licit cannabis source.
Original research | 2021
Policy/Regulatory, Decriminalization/legalization, Barriers and enablers, Stigma

Measures to support a safer drug supply

Commentary on Tyndall
Letter | 2020
Policy/Regulatory, Hesitancy of prescribers , Safer supply, Decriminalization/legalization, Equity, Advocacy, About prescribers, Barriers and enablers

Opioid overdose deaths and the expansion of opioid agonist treatment: A population-based prospective cohort study

To estimate the causal effects of a national opioid agonist treatment (OAT) program on population level drug fatalities.
Original research | 2021
Overdose, Mortality, Evidence base, Harm reduction, Policy/Regulatory, Hesitancy of prescribers , Safer supply, Advocacy, About prescribers, Outcomes, Substitution/OAT

Opioid- and Stimulant-related Harms in Canada

Webpage | 2021
Overdose, Mortality, Social services, Outcomes, Illegal drugs, Sex/Gender , Hospitals

Patient, medical and legal perspectives on reentry: the need for a low-barrier, collaborative, patient-centered approach

To inform an intervention aimed at helping recently-released people with HIV and SUD, we conducted a qualitative study to assess barriers and facilitators to community reentry from the perspectives of
Original research | 2021
Harm reduction, Wrap-around services, About PWUD, Social services, Legal system/law enforcement, Illegal drugs

Affiner votre recherche

Mots clés
Format
Région